Marie Godar

497 total citations
7 papers, 306 citations indexed

About

Marie Godar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Hematology. According to data from OpenAlex, Marie Godar has authored 7 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Marie Godar's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Platelet Disorders and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marie Godar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Platelet Disorders and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marie Godar collaborates with scholars based in Belgium, France and United Kingdom. Marie Godar's co-authors include Hans de Haard, Christophe Blanchetot, Bart N. Lambrecht, Guy Brusselle, Adrian C. Newland, Marc Michel, Blanca Sánchez‐González, László Rejtő, Peter Ulrichts and E. Sally Ward and has published in prestigious journals such as Blood, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Marie Godar

7 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marie Godar Belgium	7	98	91	90	90	58	7	306
Boaz Palterer Italy	12	111 1.1×	49 0.5×	34 0.4×	25 0.3×	61 1.1×	33	362
Jacques‐Eric Gottenberg France	9	107 1.1×	119 1.3×	36 0.4×	30 0.3×	39 0.7×	9	328
Stuart Weisman United States	5	136 1.4×	29 0.3×	110 1.2×	168 1.9×	68 1.2×	7	415
Delphine Mariotte France	10	114 1.2×	39 0.4×	36 0.4×	19 0.2×	96 1.7×	31	347
Peter Y. Chang United States	11	38 0.4×	25 0.3×	53 0.6×	62 0.7×	115 2.0×	33	479
Gerardo Orozco‐Barocio Mexico	10	136 1.4×	56 0.6×	32 0.4×	15 0.2×	45 0.8×	23	305
Rosanna Dammacco Italy	8	63 0.6×	43 0.5×	36 0.4×	65 0.7×	18 0.3×	19	454
Masaki Hiraguri Japan	9	104 1.1×	58 0.6×	17 0.2×	32 0.4×	32 0.6×	15	404
Hanns M. Lorenz Germany	6	109 1.1×	44 0.5×	29 0.3×	16 0.2×	68 1.2×	7	297
Shinichiro Nakachi Japan	10	177 1.8×	33 0.4×	26 0.3×	25 0.3×	39 0.7×	11	342

Countries citing papers authored by Marie Godar

Since Specialization

Citations

This map shows the geographic impact of Marie Godar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Godar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Godar more than expected).

Fields of papers citing papers by Marie Godar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Godar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Godar. The network helps show where Marie Godar may publish in the future.

Co-authorship network of co-authors of Marie Godar

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Godar. A scholar is included among the top collaborators of Marie Godar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Godar. Marie Godar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Broome, Catherine M., Vickie McDonald, Yoshitaka Miyakawa, et al.. (2022). Efficacy and Safety of Intravenous Efgartigimod in Adults with Primary Immune Thrombocytopenia: Results of a Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial (ADVANCE IV). Blood. 140(Supplement 1). 6–8. 11 indexed citations

2.

Newland, Adrian C., Blanca Sánchez‐González, László Rejtő, et al.. (2019). Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia. Blood. 134(Supplement_1). 895–895. 9 indexed citations

3.

Newland, Adrian C., Blanca Sánchez‐González, László Rejtő, et al.. (2019). Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. American Journal of Hematology. 95(2). 178–187. 129 indexed citations

4.

Godar, Marie, Kim Deswarte, Karl Vergote, et al.. (2018). A bispecific antibody strategy to target multiple type 2 cytokines in asthma. Journal of Allergy and Clinical Immunology. 142(4). 1185–1193.e4. 43 indexed citations

5.

Godar, Marie, et al.. (2018). Therapeutic bispecific antibody formats: a patent applications review (1994-2017). Expert Opinion on Therapeutic Patents. 28(3). 251–276. 40 indexed citations

6.

Godar, Marie, Christophe Blanchetot, Hans de Haard, Bart N. Lambrecht, & Guy Brusselle. (2017). Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. mAbs. 10(1). 34–45. 61 indexed citations

7.

Godar, Marie, Virginia Morello, Anna Hultberg, et al.. (2016). Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy. Scientific Reports. 6(1). 31621–31621. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact